ClinicalTrials.Veeva

Menu

Initial Performance of a Daily Disposable Contact Lens Featuring Molded Marks

Alcon logo

Alcon

Status

Completed

Conditions

Refractive Error

Treatments

Device: Delefilcon A Multifocal Contact Lenses with Molded Mark
Device: Delefilcon A Multifocal Contact Lenses

Study type

Interventional

Funder types

Industry

Identifiers

NCT02939170
CLO870-C001

Details and patient eligibility

About

The purpose of this study is to evaluate the impact of back surface molded marks (MM) applied to delefilcon A contact lenses as measured by the incidence of ocular discomfort device-related adverse events with DAILIES TOTAL1® Multifocal contact lenses with molded marks (DT1 MF MM) and current DAILIES TOTAL1® Multifocal contact lenses (DT1 MF).

Enrollment

87 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Must sign an Informed Consent document;
  • Current wearer of commercial DAILIES TOTAL1® contact lenses;
  • Have spectacles in current prescription available to be worn in conjunction with the investigational product;
  • Manifest astigmatism less than or equal to 0.75 diopter (D) (at screening)
  • Best corrected distance visual acuity (BCVA) greater than or equal to 20/25 in each eye;
  • Other protocol-specified inclusion criteria may apply.

Exclusion criteria

  • Eye injury in either eye within 12 weeks prior to study enrollment;
  • Any anterior segment infection, inflammation, disease, or abnormality that contraindicates contact lens wear;
  • Any use of systemic or ocular medications for which contact lens wear could be contraindicated;
  • History of herpetic keratitis, refractive surgery or irregular cornea;
  • A pathologically dry eye that precludes contact lens wear;
  • Concurrent participation in a contact lens or contact lens care product clinical trial within the previous 30 days;
  • Monocular (only 1 eye with functional vision);
  • Other protocol-specified exclusion criteria may apply.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

87 participants in 2 patient groups

DT1 MF MM
Experimental group
Description:
Delefilcon A multifocal contact lenses with molded marks on back surface worn bilaterally (in both eyes) for 9 hours
Treatment:
Device: Delefilcon A Multifocal Contact Lenses with Molded Mark
DT1 MF
Active Comparator group
Description:
Delefilcon A multifocal contact lenses worn bilaterally for 9 hours
Treatment:
Device: Delefilcon A Multifocal Contact Lenses

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems